Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

RB Walter, M Othus, Bob Löwenberg, GJ Ossenkoppele, SH Petersdorf, T Pabst, MC Vekemans, FR Appelbaum, HP Erba, EH Estey

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)E409-E411
Issue number10
Publication statusPublished - 2015

Research programs

  • EMC MM-02-41-03

Cite this